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Insights Into Leukocyte Trafficking in
Inflammatory Arthritis – Imaging the
Joint
Julia E. Manning†, Jonathan W. Lewis†, Lucy-Jayne Marsh and Helen M. McGettrick*
Rheumatology Research Group, Institute of Inflammation and Ageing, University of Birmingham, Birmingham,
United Kingdom
The inappropriate accumulation and activation of leukocytes is a shared pathological
feature of immune-mediated inflammatory diseases (IMIDs), such as rheumatoid arthritis
(RA) and psoriatic arthritis (PsA). Cellular accumulation is therefore an attractive target
for therapeutic intervention. However, attempts to modulate leukocyte entry and
exit from the joint have proven unsuccessful to date, indicating that gaps in our
knowledge remain. Technological advancements are now allowing real-time tracking
of leukocyte movement through arthritic joints or in vitro joint constructs. Coupling
this technology with improvements in analyzing the cellular composition, location and
interactions of leukocytes with neighboring cells has increased our understanding of the
temporal dynamics and molecular mechanisms underpinning pathological accumulation
of leukocytes in arthritic joints. In this review, we explore our current understanding of
the mechanisms leading to inappropriate leukocyte trafficking in inflammatory arthritis,
and how these evolve with disease progression. Moreover, we highlight the advances
in imaging of human and murine joints, along with multi-cellular ex vivo joint constructs
that have led to our current knowledge base.
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OVERVIEW OF THE LEUKOCYTE RECRUITMENT CASCADE
Over the last 30 years, the general understanding of how leukocytes migrate out of the blood,
across the endothelium and through inflamed tissues has been extensively researched providing
us with a step by step cascade of events (Figure 1) (Ley et al., 2007; Vestweber, 2015). In line
with this, imaging techniques for analyzing the individual steps of the cascade, from leukocyte
capture through to migration into the tissue, have improved exponentially giving us much more
granularity on the temporal and dynamic kinetics of these events and the key molecules involved.
Chronic inflammatory arthritis is characterized by the aberrant accumulation and activation of such
leukocytes within the synovial tissue, along with tissue-resident stromal cells (fibroblasts) becoming
epigenetically reprogrammed, both of which drive tissue and bone damage leading to pain and
immobility in patients with, for example, rheumatoid arthritis (RA) or psoriatic arthritis (PsA). The
clinical urgency to identify new drug targets that limit the trafficking of pathogenic leukocytes and
promote the entry of regulatory cells into chronically inflamed tissues, such as the joint, are partly
responsible for driving forward the imaging techniques necessary to visualize these processes in
real-time. Here, we explore our current understanding of the mechanisms leading to inappropriate
leukocyte trafficking in inflammatory arthritis, and how these evolve with disease progression.
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We provide a historic overview of the imaging techniques that
have led to our current knowledge base – considering our
progression from 2-D imaging of tissue sections; through to
in vitro adhesion and migration assays on sections, purified
proteins or single-cell layers; into the realm of real-time imaging
of 3-D multicellular ex vivo joint constructs or whole joints, and
beyond. For each technique we will highlight the key kinetics,
leukocyte subpopulations and molecules discovered and how
these advanced our understanding of process-driven pathology
of inflammatory arthritis.
IMAGING SYNOVIAL TISSUE – EARLY
INSIGHTS INTO PATHOLOGY
As early as the 1960’s researchers used haematoxylin and eosin
(H&E) to stain tissue sections to visualize tissue architecture
(Campbell-Thompson et al., 2012) (Figure 2A) and cellular
accumulation in the joints from patients with RA or PsA
(Muirden and Senator, 1968; Muirden and Mills, 1971). Time-
course experiments in murine models of inflammatory arthritis
revealed the accumulation of leukocytes peaked 1–2 days after
onset of adjuvant-induced arthritis (AIA) model (Szántó et al.,
2004; Gonçalves et al., 2020), day 10 in the KRN serum transfer
induced arthritis (STIA) model (LaBranche et al., 2010); and
21 days after immunization in the collagen-induced arthritis
(CIA) model (Knoerzer et al., 1997). Similarly, H&E revealed a
substantial number of leukocytes accumulating in the synovium
of patients with early (disease duration less than 1 year) and
established RA (1.5–20 years), with the degree of infiltration
correlating with disease activity rather than symptom duration
(Baeten et al., 2000). For both human and murine studies, H&E
analysis of synovium has highlighted the significant role of
tumor necrosis factor-α (TNFα) in driving leukocyte infiltration
into the inflamed joint: with TNFα inhibitors (TNFi) reducing
leukocyte numbers in the joint leading to reduced clinical scores,
which were not seen in non-responders (Williams et al., 1992;
Baeten et al., 2000; Barrera et al., 2001), as well as reducing
the expression of chemokines within the synovium (Taylor
et al., 2000). Similarly, H&E revealed a potential therapeutic
benefit of inhibiting chemokine interactions in AIA, where short-
chain peptides modeled on the chemokine glycosaminoglycan
binding domain of CXCL8 (interleukin-8) decreased leukocyte
accumulation and the overall inflammatory score in treated
joints (McNaughton et al., 2018). Whilst H&E analysis of tissue
sections is an integral outcome measure in almost all studies,
it is unable to provide any insight into the specific subsets of
leukocytes infiltrating the joint, how these evolve with disease or
the mechanisms underpinning their accumulation.
Advances in immunohistochemistry (IHC) and subsequently
fluorescence microscopy and in situ hybridization (ISH) have
expanded our ability to identify individual leukocyte subsets in
synovial tissue sections (Menon et al., 2017; Traylor-Knowles,
2018) (Figures 2B,C), furthering our understanding of the
composition of leukocytes within the inflamed joint in the various
murine models of inflammatory arthritis and human arthritides.
For example, monocytes and CD4 T-cell infiltration peaked
2–3 days following onset of AIA, followed by an influx of CD8
T-cells and B-cells which peaked at day 7 (Verschure et al.,
1989). Moreover, monocytes and macrophages were observed
in the sublining layer of the AIA joint, whilst T and B-cells
were located in perivascular clusters and some in small isolated
groups (Dijkstra et al., 1987). Indeed, elevated numbers of CD3+
T-cells, CD20+ B-cells, and CD68+ macrophages, along with
a concomitant decrease in the numbers of regulatory T-cells
(Tregs) were also observed using IHC in synovial biopsies from
RA patients with high disease activity scores compared to patients
with lower disease activity or in remission (Zhang et al., 2005;
Behrens et al., 2007; Alivernini et al., 2017). Moreover, anti-
TNFα therapy reduced the numbers of CD3+ T-cells, CD22+
B-cells, and CD68+ macrophages in the joints of patients with
RA over a 2 weeks period (Taylor et al., 2000). Indeed, the
combination of CD20, CD138 (marking plasma cells), CD3,
and CD68 revealed 3 distinct leukocyte profiles (pathotypes)
in the synovium of patients with early and established RA
based on the absence of leukocytes (pauci-immune), diffuse
myeloid infiltrate or the formation of lympho-myeloid aggregates
(Humby et al., 2019; Nerviani et al., 2020). Agreeing with
earlier studies that described pauci-immune; diffuse and follicular
infiltrates (Wagner et al., 1998; Pitzalis et al., 2013). Crucially
these different leukocyte synovial pathotypes impact on a patient’s
response to therapy – where over 80% of patients with a lympho-
myeloid or diffuse myeloid pathotype showed a decrease in
their disease activity (DAS28 score) following treatment with
the anti-TNFα drug, certolizumab-pegol, whilst less than 30% of
patients with the pauci-immune pathotype responded (Nerviani
et al., 2020). Such studies reveal two important insights –
firstly leukocyte pathotypes highlight the existence of different
leukocyte recruitment and retention signatures in subgroups of
RA patients. Secondly, although the exact molecular mechanisms
for these signatures remain undetermined, TNFα clearly plays
a major role in the two pathotypes where elevated levels of
leukocytes are observed.
Early IHC and ISH studies revealed for the first time the
expression pattern of adhesion molecules and chemokines within
arthritic joints (Johnson et al., 1993; Salmi et al., 1997; Matsui
et al., 2001; Wang et al., 2004). Macroscopically, expression of
certain adhesion molecules (selectins and VCAM-1) have been
reported to be restricted to a subpopulation of synovial vessels
in patients with chronic arthritis; whilst others [intracellular
adhesion molecules 1 and 2 (ICAM-1 and ICAM-2)] were
ubiquitously expressed (Salmi et al., 1997). In contrast, little
E-selectin was detected on vessels in PsA (Veale et al., 1993).
Synovial blood endothelial cells located near or within tertiary
lymphoid structures appear to acquire a high endothelial vessel
(HEV)-like phenotype with the expression of peripheral node
addressin (PNAd), an adhesion molecule normally restricted
to HEV’s, observed on synovial endothelial cells in some, but
not all, RA and PsA sections analyzed (Salmi et al., 1997;
Cañete et al., 2007) – and which may account for the lympho-
myeloid/follicular pathotype described (Wagner et al., 1998;
Pitzalis et al., 2013). Similarly, rheumatoid synovial endothelium
abnormally expresses high levels of the mucosal specific vascular
adhesion protein-1 (VAP-1) (Salmi et al., 1997) – indicating that
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the synovial endothelium acquires the capacity to support the
trafficking of gut-homing T-cells during RA pathology. Crucially,
the activation status of synovial endothelial cells is sensitive
to anti-TNFα therapy, with reduced expression of E-selectin
(Paleolog et al., 1996; Tak et al., 1996) and vascular cell adhesion
protein 1 (VCAM-1) (Tak et al., 1996) reported in the rheumatoid
synovium following treatment – almost certainly accounting
for the improvement in disease activity seen in patients with
leukocyte rich pathotypes (Nerviani et al., 2020).
In 1976 Stamper and Woodruff transformed tissue analysis
from spatial 2-D phenotypic studies to 3-D functional assays
(Hirata et al., 2004) (Figure 2D), by allowing lymphocytes
to adhere to fixed murine lymph node tissue sections before
visualizing their interactions using methyl-green-thionin and
light microscopy (Stamper and Woodruff, 1976). Subsequently,
groups adapted the Stamper–Woodruff (S–W) assay and began
assessing the molecular mechanisms supporting leukocyte
adhesion to arthritic synovial tissue. For example, significantly
more monocytes adhered to RA synovium compared to other
tissues analyzed (foreskin, placenta, and inflamed tonsils), and
blocking the capture receptors P-selectin and E-selectin reduced
this by >90% and 20–50%, respectively (Grober et al., 1993).
Similarly, HL-60 cell (a neutrophil-like leukaemic cell line)
adhesion to frozen sections of RA synovium was significantly
reduced following treatment with an anti-E-selectin function-
blocking antibody or the TNFα inhibitor certolizumab pegol (Shu
et al., 2012). Thus demonstrating a pivotal role TNFα, P- and
E-selectin in supporting neutrophil and monocyte recruitment
to the RA synovium. Furthermore, Salmi et al. (1997) revealed
for the first time mucosal lymphocytes bind to VAP-1 expressed
by RA synovial vessels, further supporting the concept that gut-
specific trafficking address-codes for lymphocytes are hijacked
by the rheumatoid joint. Indeed, the mucosal microbiome is
now believed to play a crucial role in lymphocyte trafficking
outside the inflamed joint, and is highly likely to influence
the phenotype of the cells recruited to the joint (reviewed by
Buckley and McGettrick, 2018; Manasson et al., 2020; Xu et al.,
2020). This functional analysis of tissue sections allowed for the
first time mechanistic studies on the proportion of leukocytes
binding with or without interventions to be analyzed. Further
studies using tissues from other inflammatory arthritides and at
different phases of disease are now required to distinct shared





TRAFFICKING – THE CREATION OF
IN VITRO JOINT CONSTRUCTS
The vast majority of our understanding on the dynamics of
leukocyte recruitment has been discovered by visualizing cell–
cell interactions in vitro using assays that incorporate purified
proteins or different tissue-resident cells (e.g., blood vascular
endothelial cells or fibroblasts) in either 2-D or 3-D formats,
and in some cases that also mimic blood flow (Butler et al.,
2009; Mcgettrick et al., 2017). These in vitro static or flow-
based adhesion/migration assays enable the real-time imaging
of leukocyte behavior as they interact with the substrate,
including their motility (Figures 2E,F). As such they have
been a vital tool in aiding our understanding of the molecular
processes governing disease onset and perpetuation in many
arthritides, especially when patient cells or pharmacological
agents have been assessed.
2-Dimensional Models
Surprisingly few studies have visualized each step of the
adhesion cascade using leukocytes isolated from patients with
inflammatory arthritis and models mimicking the joint that
incorporate endothelial cells alone or with relevant stromal
components (Figures 2E,F). For example, more T-cells adhered
and migrated through inflamed endothelium in vitro when they
were isolated from RA (Taylor et al., 2000) or PsA (Dunky
et al., 1997) patients compared cells from the control group –
this was thought to be mediated by αLβ2-integrin. Interestingly,
the adhesive capability of T-cells appeared to be unaffected by
whether a patient exhibits active or inactive RA, with similar
numbers of fluorescently labeled T-cells observed binding to
either resting or IL-1β stimulated endothelial cells over a 6-
h timeframe (Mertens et al., 1994). Similarly, greater numbers
of effector memory CD4+ T-cells from RA patients migrated
further into collagen gels over 48 h following in vitro anti-CD3+
CD28-induced activation compared to cells isolated from healthy
controls (Shen et al., 2017). Combining these data with IHC
and metabolite quantification revealed that T-cells from these
clinically active RA patients had reduced glycolytic flux that
resulted in the overexpression of TSK5, a podosome scaffolding
protein found at the leading edge of the cells causing enhanced
migratory capacity in vitro (Shen et al., 2017). This was one of
the first studies to highlight the importance of disease-induced
metabolic changes in leukocytes on their adhesive and migratory
potential. Similar observations have been linked to genes
associated with increased risk of developing RA – for example,
super-resolution studies revealed that the expression of the
PTPN22 variant (PTPN22W) increased αLβ2-integrin clustering
in T-cells resulting in them being more sticky (Burn et al., 2016).
Genetic risk factors and abnormal cellular metabolism promote
the adhesive and migratory properties of T-cells in patients with
RA (Weyand et al., 2020), and potentially other inflammatory
arthritides by altering the expression levels or cellular localization
of αLβ2-integrin. Whilst directly targeting αLβ2-integrin is not
a viable treatment option [see review on leukocyte adhesion
deficiency (Harlan, 1993; Kuijpers et al., 1997)], targeting the
processes regulating its expression and distribution may provide
alternative treatment options for arthritides.
TNFα signaling, itself, can induce leukocytes to shed β2-
integrins (Gjelstrup et al., 2010), resulting in increased plasma
soluble β2-integrin (sCD18) concentrations that bind to ICAM-
1 on the endothelium to reduce the availability of this molecule
to leukocytes, thus reducing adhesive interactions (Kragstrup
et al., 2014). However, this homeostatic regulatory pathway is
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FIGURE 1 | The multi-step leukocyte adhesion cascade. Infection or tissue damage causes the localized release of danger signals, including cytokines, which (1)
activate the endothelium causing the expression of capture receptors (P- or E-selectins), adhesion molecules (IgSF members – ICAM-1; VCAM-1) and presentation
of chemokines or lipids on their surface (2) (Zhang et al., 2011). Marginated leukocytes are captured, roll along the endothelial surface until (3) they receive an
activation signal (typically chemokine mediated) resulting in inside-out signaling and integrin activation (αLβ2-integrin; α4β1-integrin) (Ley et al., 2007). This allows for
stabilization of the adhesive interactions (αLβ2-ICAM-1 and α4β1-VCAM-1 interactions) and cytoskeletal rearrangement in the leukocyte allowing (4) them to crawl
over the endothelium, migrate across the endothelium (ICAM-1; JAM-1; CD31; VE-cadherin) and into the subendothelial space (Ley et al., 2007), (5) where they
encounter the basement membrane and stromal compartment. This process is tightly regulated by the haemodynamic forces of the flowing blood and the stromal
derived signals experienced by the endothelium (McGettrick et al., 2012). Some of the major molecules involved in this process are represented in the schematic,
with molecules colored according to cell type expressing them; leukocytes = blue; endothelial cells (ECs) = red and expressed by both leukocytes and ECs = green.
ICAM-1, Intracellular adhesion protein 1; IL-8, interleukin-8; JAM, junctional adhesion molecule; PECAM-1, platelet endothelial cell adhesion molecule 1; PSGL1,
P-selectin glycoprotein ligand-1; VE-cadherin, vascular endothelial cadherin; VCAM-1, vascular adhesion protein 1. Created with BioRender.com.
lost in patients with RA and spondyloarthritis (SpA) (Kragstrup
et al., 2014), where patients with high disease activity scores have
lower plasma sCD18 compared to OA, and thus the potential
for elevated levels of leukocyte trafficking (Gjelstrup et al., 2010).
Furthermore, B-cells from patients with RA have lost their ability
to respond to the adipokine, adiponectin, and therefore their
ability to release the peptide hormone, PEPITEM, which acts to
limit T-cell migration into inflamed tissues (Chimen et al., 2015).
So in addition to lymphocytes acquiring pro-migratory traits,
there is also a loss of tonic regulators that normally act to limit
tissue infiltration in patients with RA and SpA.
Considering other leukocyte subtypes, patients with RA
have higher levels of “reverse migrated” neutrophils in their
circulation, suggesting that these cells have sampled the
tissue microenvironment and re-entered the circulation across
the blood vascular endothelial cells rather than through the
lymphatics (Buckley et al., 2006). Moreover, expression of RA
susceptibility gene, PTPN22W, enhanced neutrophil migration
across TNFα-activated endothelium in vitro (Bayley et al.,
2015) and may account for the rapid transit of neutrophils
through the rheumatoid joint into the synovial fluid. RA
neutrophil chemotaxis toward the synovial fluid rich CXCL8
(IL-8) was blocked with the Janus kinase inhibitors (JAKi)
(Mitchell et al., 2017), along with reduced neutrophil and
T-cell numbers observed in the joints of RA patients treated
with barictinib (Tanaka et al., 2018) – suggesting JAKi have
potential therapeutic benefit by limiting leukocyte migration
in arthritic patients. The higher expression the αM subunit of
the αMβ2-integrin on monocytes from RA patients contributed
to their enhanced adhesion to resting (uninflamed) and IL-
1β stimulated endothelium in vitro when compared to the
levels observed for monocytes from normal controls (Lioté
et al., 1996). By contrast, fewer fluorescently labeled monocytes
migrated through TNFα activated human dermal microvascular
endothelial cells when they were isolated from PsA patients,
compared to monocytes from patients with osteoarthritis,
fibromyalgia or type-2-diabetes (as controls) – most likely due to
a reduction in surface expression of the αMβ2-integrin required
for stable/firm adhesion, explaining the reduced number of
monocytes in the psoriatic joint, compared to RA (Neumüller
et al., 2001). Akin to lymphocytes, pathological alterations in
the expression of the β2-integrins by neutrophils and monocytes
contribute to the synovial leukocyte composition in these
inflammatory arthritides.
Synovial blood vascular endothelial cells (sEC) act as
the gatekeepers to the joint. Crucially, Abbot et al. (1999)
demonstrated that sEC from RA patients are imprinted with
a disease-specific tissue memory and are in a pre-primed
state that is maintained in culture. This pathogenic phenotype
enables TNFα-stimulated rheumatoid sEC to support greater
levels of neutrophil and T-cell capture from flow and induced
stable adhesion (Abbot et al., 1999). Further research examining
the phenotype of sEC through the evolution of inflammatory
arthritides, across diseases and its impact on the inflammatory
infiltrate is urgently required. Similarly, synovial fibroblasts from
inflammatory arthritides are epigenetically imprinted with a
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FIGURE 2 | Methodologies for imaging leukocyte infiltration. (A) H&E staining (Tucker et al., 2016): decalcified joints are paraffin embedded, sectioned, and stained
with H&E to identify leukocyte infiltration. (B) Immuno-fluorescence (Honvo-Houéto and Truchet, 2015; JoVE, 2021): tissue sections are stained with fluorescently
tagged antibodies against specific proteins to visualize cellular localization using a fluorescent microscope. Representative image shows a lymph node stained for
CD3+ (Red), CD4+ (Blue), and FoxP3+ (Green) T-cells. In (A,B), images courtesy of Miss Jenefa Begum (University of Birmingham). (C) In Situ Hybridization (Menon
et al., 2017): an RNA-specific target probe is added to tissue sections, where it hybridizes to its corresponding gene. Amplification probes are added to enhance the
detection, which are bound by detection probes. Detection probes can either be fluorescent-, antibody- or radio- labeled. Image of arthritic joint replacement tissue
section stained for PDGFRβ (Red), nuclei (Pale Blue), and CD90 (Brown), courtesy of Dr. Triin Major (University of Birmingham). (D) Stamper–Woodruff assay (Hirata
et al., 2004): leukocytes are added to frozen tissue sections on slides and rotated for 30 min. Non-adherent cells are washed off and the section stained with nuclear
dye and/or antibodies of choice. Image courtesy of Dr. Patricia Lalor and Dr. Sarah Edwards (University of Birmingham, Edwards et al., 2006). (E,F) Static and flow
based adhesion assays (Butler et al., 2009): Endothelial cells or the ligand of interest are seeded onto the well, a filter or onto a collagen gel and treated with
stimulant(s) of choice (e.g., TNF-α) for the desired amount of time. Stromal cells can be cultured beneath the endothelium to assess how they regulate endothelial
recruitment of leukocytes (Munir et al., 2015; Mcgettrick et al., 2017). (E) Leukocytes are added to the well and left to adhere under static conditions, before
non-adherent cells washed off and remaining adherent cells imaged via phase contrast microscopy. Image courtesy of Miss Sophie Hopkin (University of
Birmingham). (F) Leukocytes are perfused across the surface (e.g., endothelial cells or purified protein/carbohydrate) at a wall shear rate determined by the flow rate
of a syringe pump. In (E,F), adherent cells appear circular and phase bright, as they become activated and migrate they change morphology and appear phase dark
once underneath the endothelial monolayer. (G) Organ-on-a-chip (Rothbauer et al., 2020): a micro-scale system to mimic the environment within the human body,
combining cultured cells and microfluidic systems – where leukocytes are perfused through a channel coated with endothelial cells, with pericytes and stromal cells
cultured on the opposite (basal) side to the endothelial cell. (H) PET imaging (White et al., 2017; Momcilovic et al., 2018): cells are tagged using a radioactive tracer
that emits a small quantity of Gamma rays. Tagged cells are injected into participants and the location of cells can be tracked and imaged. (I) Two photon
microscopy (Chen et al., 2017; Cai et al., 2019): fluorescently labeled cells are visualized and their movement tracked in real-time with two-photon microscope either
in vivo and ex vivo. Image of human liver tissue perfused with wheat germ agglutinin and Hoechst and imaged ex vivo, courtesy of Dr. Scott P. Davies (University of
Birmingham). (J) Bioluminescence (Lim et al., 2009): cell specific luciferase knock-in lines are visualized using the whole animal in vivo imaging system (IVIS), allowing
the tracking of endogenous or injected cells. Image shows 1,1′-dioctadecyltetramethyl indotricarbocyanine Iodide tagged bone marrow mesenchymal stem cells
accumulation following injection into wildtype mice; courtesy of Dr. Lozan Sheriff (University of Birmingham). (K) Kaede mice (Porter et al., 2018; Steele et al., 2019):
UV light illumination of tissues (e.g., draining lymph nodes) in situ photoconverts cells from green to red fluorescence. The movement of red fluorescent cells to, and
their interaction with cells at, distant tissues can be tracked. In (A–F,I), arrows denote leukocytes on the representative images. Created with BioRender.com.
pathogenic phenotype (Parsonage et al., 2005). For example, RA
synovial fibroblasts support elevated levels of B-cell (Shimaoka
et al., 1998; Burger et al., 2001) and T-cell (Bradfield et al., 2003)
pseudoemperipolesis (sub-fibroblast migration) in a CXCL12
dependent manner compared to dermal fibroblasts. Further
to this, peripheral blood CD4+ T-cells from RA patients
exhibit higher expression of the α6 integrin subunit and
were more efficiently captured from flow to the extracellular
matrix components, laminin and fibronectin, than control cells
(Haworth et al., 2008). These interactions are likely to be
responsible for localizing CD4+ T-cells in the laminin bordered
perivascular cuff in the rheumatoid joint (Haworth et al., 2008) –
as observed by confocal microscopy on tissue sections. Whilst
neutrophils from healthy controls and clinically active RA bind
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at similar levels to fibronectin in vitro, significantly fewer cells
adhered when they were isolated from patients in clinical
remission – these observations were linked to reductions in the
expression of L-selectin and αL-integrin on neutrophils following
anti-TNFα therapy (Dominical et al., 2011). These studies start
to elucidate the molecular mechanisms responsible for leukocyte
interactions in the subendothelial space, and how these are
altered by drug-induced clinical remission.
The combination of altered adhesive and migratory properties
of leukocytes and endothelial cells in patients with RA further
amplifies the aberrant trafficking of inflammatory cells during
disease – the critical question of which cell type becomes
dysregulated first remains to be answered.
3-Dimensional Models
Over the last 20 years, considerable effort has been made to
address the limitations of 2-D culture systems in an attempt
to generate a more representative 3-D model of the tissue
(McGettrick et al., 2012; Buckley and McGettrick, 2018), in
which leukocyte trafficking under static and physiological flow
conditions can be observed (Munir et al., 2015; Mcgettrick et al.,
2017) (Figure 2F). As a result, it is clear that tissue-resident
stromal cells communicate with the neighboring endothelial
cells to generate “stromal address codes” for tissue-specific and
disease-specific regulation of leukocyte trafficking (Parsonage
et al., 2005). Crucially the absence of these signals results in
lymphocyte migration being frustrated, such that they shuttle
back and forth across the inflamed endothelial barrier, with
few cells penetrating a 400 µm deep collagen gel (McGettrick
et al., 2008; Jeffery et al., 2013). A series of studies using
phase-contrast microscopy has revealed that primary synovial
fibroblasts from patients with acutely resolving synovitis or
primary dermal fibroblasts from patients with RA undergoing
joint replacement surgery limit the ability of endothelial cells
to recruit lymphocytes from flow - in effect acting in an anti-
inflammatory manner (McGettrick et al., 2009; Filer et al.,
2017). By contrast, synovial fibroblasts from patients with RA
undergoing joint replacement surgery were able to stimulate the
endothelium, such that they were able to recruit neutrophils and
lymphocytes in the absence of any other exogenous cytokines -
thus exerting a pro-inflammatory action (Rainger et al., 2001;
Lally et al., 2005; Smith et al., 2008; McGettrick et al., 2009; Filer
et al., 2017). In particular, this response was due to the trafficking
and presentation of fibroblast-derived chemokines (CXCL5 and
CXCL12) on the endothelial surface, and enhanced leukocyte
capture mediated through P-selectin (neutrophils) and α4β1-
integrin-VCAM-1 interactions (lymphocytes) (Lally et al., 2005;
McGettrick et al., 2009). Interestingly the synovial fibroblasts
from patients at the earliest phase of RA communicate with the
endothelium in a manner that is distinct from fibroblasts isolated
from resolving synovitis (i.e., they do not suppress cytokine-
induced lymphocyte recruitment), and also from fibroblasts from
patients with RA undergoing joint replacement surgery [i.e., they
are unable to activate the endothelium to recruit leukocytes in
the absence of cytokines (Filer et al., 2017)] – this crucially
reveals that the cross-talk, and therefore the patterns of leukocyte
trafficking in RA, evolve as the disease progresses and suggest
that therapies targeting these processes should also change as
the disease evolves. Furthermore, blocking either hydrocortisone
or IL-6 was able to reverse the pro-inflammatory effects of
fibroblasts from patients with RA who had to undergo joint
replacement surgery (Lally et al., 2005; Smith et al., 2008;
McGettrick et al., 2009), adding further evidence to the mode of
action of glucocorticoid or tocilizumab therapy in these patients.
Of note, all these studies focused on the interaction of fibroblasts
from patients with inflammatory arthritis with endothelial
cells isolated from healthy donors. Additional studies are now
required to expand this further by incorporating patient-derived
sEC’s that exhibit disease-specific phenotypes (as highlighted
above) and to elucidate the impact this has on the ability of
fibroblasts to regulate leukocyte trafficking. Furthermore, there is
also a need to broaden the inflammatory arthritides from which
cells are isolated to reveal those features of arthritis that are
shared across a range of arthritides and those that are unique.
IMAGING LEUKOCYTE TRAFFICKING
IN VIVO – OBSERVATIONAL STUDIES
The regulation of leukocyte trafficking is multifactorial –
involving blood flow; endothelial and stromal responses.
Similarly, inflammatory arthritides can be systemic diseases,
affecting multiple joints and other organ systems. The only
way to truly understand how arthritic pathology influences the
kinetics, spatial location and molecular mechanisms of leukocyte
migration into, through and away from the joint is through
in vivo analysis – either preclinical murine models of disease
or imaging of patients joints. However, these approaches are
significantly more complicated than those we have discussed
above, due to the intricate nature of joints (Gompels et al., 2010).
As a result, most studies to date have focused on mapping cellular
movement, with few conducting mechanistic investigations.
Initial efforts to observe infiltration of human leukocytes
movement in real-time began by metal-tagging purified
leukocytes subsets and re-injecting them back into the subject,
allowing the small gamma particles released by the tagged cells
to be detected and tracked (Uno et al., 1986; Dudhia et al.,
2015). Tagging human leukocytes with indium-111 (111In)
revealed the accumulation of tagged cells in the joints of human
patients with swelling and active RA, which were not observed
in patients where swelling and pain were not present (Uno
et al., 1986) or those with inactive disease (Uno et al., 1992).
Moreover, anti-TNFα therapy reduced 111In-labeled granulocyte
trafficking into patient joints over 22 h (Taylor et al., 2000).
Techniques subsequently progressed to enable tagging of specific
cell types, such as anti-T-cell (CD3) technetium-99m (99mTc)
tagged antibodies, which were observed accumulating in the
moderately or severely painful joints in RA and PsA patients,
but not in those joints where pain levels were low or absent
(Marcus et al., 1994). Indeed, clinically active and inactive
joints have also been identified using radiolabeled E-selectin
in patients with RA (Chapman et al., 1994; Chapman et al.,
1996; Jamar et al., 2002). Once again, anti-TNF-α therapy
(adalimumab) decreased 99mTc-labeled leukocyte accumulation
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into the joints of RA patients 2 weeks after the treatment
onset, which subsequent studies suggested that this was due to
increased 99mTc monocyte/macrophage egress from the joint
as numbers of monocytes entering remained unaffected by
adalimumab treatment (Thurlings et al., 2009; Herenius et al.,
2011). Similarly, metal tagged antibodies against E-selectin
have also revealed its up-regulation in porcine arthritic joints
but not control joints (Chapman et al., 1994). Thus linking
the active movement of T-cells into the joint and changes in
capture receptor expression with swelling, pain and disease
activity experienced by the patients. Similarly, blood neutrophils
tagged with technetium-99m hexametazime were observed
ingressing into the rheumatoid joint over 22 h by gamma
camera imaging, a response that was blocked by glucocorticoid
therapy (methylprednisolone) (Youssef et al., 1996). By contrast,
when synovial fluid neutrophils tagged with 111In were injected
intra-articularly their egress from the synovial space into the
periphery was unaffected by methylprednisolone treatment
(Youssef et al., 1996). Further supporting the involvement
of migrating neutrophils in the RA pathology, and the
beneficial action of glucocorticoid therapy on limiting their
movement/effector functions.
Positron emission tomography (PET) tracers allow a non-
invasive means to measure cellular accumulation (White et al.,
2017; Momcilovic et al., 2018) (Figure 2H). For instance, higher
levels of the PET tracer [18F]F-AraG were detected in the
arthritic paws of AIA mice, whilst no tracer was observed in
control paws (Franc et al., 2017). Similarly, in RA and PsA
patients, the [18F]-FDG PET tracer was shown to accumulate
at sites of synovitis, but not in unaffected joints (Chaudhari
et al., 2016). Thus, indicating an accumulation of activated
immune cells in the arthritic joint, which could result from either
increased leukocyte migration or enhanced proliferation of the
cells within the tissue or a combination of both. Protein specific
PET tracers, such as 68Ga-Aquibeprin or 68Ga-Avebetrin that
bind specifically to α5β1-integrin or αVβ3-integrin, respectively,
can also be used to track the expression pattern of molecules
involved in leukocyte trafficking (Notni et al., 2019). Such tracers
showed increased expression of α5β1- and αVβ3-integrins in
arthritic joints compared to non-arthritic joints in mice with CIA
(Notni et al., 2019), suggesting arthritis increases the expression
of these integrins to facilitate leukocyte accumulation. Tracer
studies are currently limited to detecting global cellular activity
(accumulation/proliferation) but are unable to identify individual
cells or subsets or their movement.
The greatest advancement in imaging the dynamics of
leukocyte trafficking in vivo has come from the development
of two-photon microscopy, which allows tissues, including the
joints and blood vessels, of living organisms to be imaged in
real-time enabling the observer to visualize specific parts of the
adhesion cascade including velocities (Chen et al., 2017; Cai et al.,
2019) (Figure 2I). For example, leukocyte rolling and adhesion
to arthritic joints (Veihelmann et al., 1999), or neighboring
tendons [achilles and patella (Gál et al., 2005)], increased in a
time-dependent manner in the initial phases of the disease, after
which the number (Veihelmann et al., 1999) and velocity (Gál
et al., 2005) of rolling cells steadily declined, whilst the absolute
numbers of adherent cells remained elevated in both AIA and
proteoglycan induced arthritis (PGIA) models relative to the
control animals. Moreover, rolling velocities increased at early
time points (4 h) and absolute numbers of adherent leukocytes
were reduced over the first 24 h in L-selectin knockout mice
with AIA - observed using intravital microscopy of the synovial
post-capillary venules (Szántó et al., 2004). Similarly, more LysM-
eGFP granulocytic myeloid cells were observed moving at a much
slower mean migration velocity through metatarsal tissue of AIA
mice using intravital microscopy compared to controls (Byrne
et al., 2012). Moreover, adoptively transferred fluorescently
labeled antigen-presenting cells (APC) isolated from the spleen
and draining lymph nodes of PGIA mice were detected inside
the ankles of severe combined immunodeficient (SCID) mice
by multiphoton imaging (Angyal et al., 2010). However, when
splenic T-cells were transferred they were only detected in the
lymph nodes, revealing low levels of T-cell migration directly into
the joint following induction of PGIA (Angyal et al., 2010). Near-
infrared whole animal imaging tracked the increased infiltration
of F4/80+ monocyte/macrophages into arthritic joints over the
first 6 h of AIA (Hansch et al., 2004). Taking this further,
biofluorescence whole animal imaging studies revealed the more
effective localization of anti-TNFα drugs (certolizumab pegol,
adalimumab, and infliximab) to arthritic joints than non-arthritic
joints in mice with CIA (Palframan et al., 2009).
Alternative strategies employing the use of bioluminescence,
commonly involving luciferase, avoid the need for excitation
of the label of interest (Figure 2J). For instance, Nakajima
et al. (2001) tracked the localization of type-II collagen
specific GFP-luciferase CD4 T-cell hybridomas following their
injection into mice with CIA using whole animal real-time
live bioluminescence imaging with the in vivo imaging system
(IVIS) over a 7 days period (Nakajima et al., 2001). Initially
GFP-luciferase CD4 T-cells were observed accumulating in the
lungs after 24 h, but subsequently moved to the arthritic joints
where the intensity of GFP-luciferase signal, and therefore the
accumulation of cells, increased between 3 and 5 days and was
still detectable at the same level 7 days post-injection (Nakajima
et al., 2001). Using this technology, the locations of specific cell
types can be observed throughout an experiment, however, it
does not provide detailed data outlining specific cell numbers.
Advances in photoconvertible reporter mice (e.g., Kaede)
are now allowing us to gain some insights into the migratory
journey of leukocytes to and from tissues. For example, in Kaede
mice, cells are converted from green to red fluorescence with a
UV light, allowing researchers to track the movement of cells
from the tissue of photoconversion into distance sites (Porter
et al., 2018; Steele et al., 2019) (Figure 2K). On a technical
note, it is crucial that tissues neighboring the photoconversion
site are appropriately shielded from the light source to avoid
converting these cells also. Whilst there are currently no
publications reporting photoconversion of an inflamed joint or
the neighboring draining lymph nodes we are aware of several
groups working in this area and await the outcome of these
studies. That said, groups have photoconverted areas of the small
intestine and colon in arthritic mice (CIA and KRN, respectively)
and detected converted cells, mainly CD4+ T-cells, in the joint
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and the draining lymph node between 1 (Morton et al., 2014)
and 4 days (Tajik et al., 2020) later by flow cytometry. Combining
these data with the earlier IHC studies from the late 1990s further
confirms the importance of the ability of gut-derived leukocytes
to migrate into arthritic joints in the pathogenesis of the disease.
Whilst advancements in imaging technologies allow the
dynamics of leukocyte trafficking patterns or the expression
profile of adhesion molecules and cytokines to be observed
in vivo, we are not yet in the position to fully track these processes
in patients over their disease and treatment journey. Improving
imaging of molecular mechanistic changes, such as alterations in
receptors and ligands, that occur as leukocytes enter and exit the
joint is essential to fully understanding these processes and to
identify targets to limit trafficking of pathogenic leukocytes whilst
promoting the movement of regulatory leukocytes necessary to





It is clear that patients with inflammatory arthritides, such
as RA or PsA, have defects in one or more of the security
checkpoints that normally regulate leukocyte trafficking (Buckley
and McGettrick, 2018) (Figure 3). Firstly synovial endothelial
cells (Abbot et al., 1999) and fibroblasts (Parsonage et al., 2005)
are imprinted with a pathogenic pro-inflammatory phenotype
that is maintained in culture, and which causes these cells to
express elevated levels of proinflammatory and pro-recruitment
mediators, such as adhesion molecules, chemokines, lipids
and cytokines (Parsonage et al., 2005). Moreover, synovial
endothelial cells acquire tissue-specific traits associated with
mucosal endothelium (VAP-1) (Salmi et al., 1997) and high
endothelial venules (PNAd) (Salmi et al., 1997; Cañete et al.,
2007) allowing the aberrant trafficking of gut-homing and lymph
node homing leukocytes to the joints, and in some cases the
formation of tertiary lymphoid structures (Morton et al., 2014;
Tajik et al., 2020). Synovial fibroblasts also display positional
memory for their location within a joint (Croft et al., 2019;
Wei et al., 2020), and differ across joints (Frank-Bertoncelj
et al., 2017) – this adds further complexity to the regulation
of leukocyte migration within the synovium itself, and for
which newer imaging modalities are just starting to reveal
insights. Finally, the bi-directional cross-talk between endothelial
cells and fibroblasts evolves as the disease progresses (Filer
et al., 2017), altering the composition of leukocytes in the joint
over the disease history. Thus pathogenic changes in the joint
tissue microenvironment actively support the aberrant leukocyte
trafficking and accumulation, and so one strategy would be to
reset the tissue microenvironment to reverse pathology. Yet,
leukocytes from these patients can also display pro-adhesive, pro-
migratory phenotypes, linked to genetics [e.g., PTPN22W (Bayley
et al., 2015; Burn et al., 2016)], altered metabolism (Pucino
et al., 2019, 2020) or protein expression [adiponectin receptors
(Chimen et al., 2015); TSK5 (Shen et al., 2017)], which tend to
lead to enhanced or prolonged αLβ2-integrin expression (Yokota
et al., 1995; Burn et al., 2016) facilitating their entry and retention
within the inflamed joint. However, this raises the “chicken and
egg” question of whether changes in the tissue or changes in
leukocytes are the first to happen. Of note, we know much more
about the molecular mechanism governing these processes in the
context of RA, than other inflammatory arthritides.
Many imaging studies using a wide range of technologies have
demonstrated the significant role TNFα plays in the initiation
and propagation of inflammation in the joints of humans with
RA (Barrera et al., 2001) and mice (Williams et al., 1992; Sudoł-
Szopińska et al., 2013). Of relevance here is the reduction in
leukocyte accumulation in arthritic joints, as well as changes
in the expression of adhesion molecules [e.g., E-selectin and
VCAM-1 (Tak et al., 1996)] and chemokines (e.g., IL-8) (Butler
et al., 1995) in response to TNFα inhibitors. Despite this, not all
RA patients respond to the various on the market, which might
be explained, at least in part, by the distinct synovium leukocyte
pathotypes observed in tissue sections from patients (Nerviani
et al., 2020). Few, if any studies have examined leukocyte numbers
or expression of key molecules involved in the recruitment
cascade for other chemical or biological disease-modifying anti-
rheumatic drugs (DMARDs). Understanding how DMARDs
impact the key components and cells of the cascade will allow
the mechanism of initiation, development and resolution of
inflammatory arthritides to be identified, possibly leading to
personalized medicine depending on disease stage.
THE FUTURE OF THE IN VITRO JOINT
Technologies to make more in vivo-like constructs are continuing
to vastly improve: ranging from 3-D self-organizing tissue culture
organoids; through to microfluidic channels and building up
to 3-D cell cultures incorporating microfluidic technology to
create organs-on-chips, and finally the fabrication of tissue-like
structures. All of these techniques have improved tremendously
over the past 10 years, but their use in studies of leukocyte
trafficking in the context of inflammatory arthritides remains
limited (reviewed by Damerau and Gaber, 2020).
Given inflammatory arthritides are driven by multiple cell–
cell interactions, 3-D organoids offer an excellent way of
interrogating these communication pathways in more detail.
Unfortunately, the 3-D nature of these constructs currently
restricts the possibility of real-time live imaging, so these models
are commonly analyzed upon sectioning as seen for whole
tissue. For example, TNFα induced the self-organization and
proliferation of a 3-D micromass of fibroblast-like synoviocytes
from RA patients into the two distinct layers found in
the joint (a lining and sublining layer), implying fibroblasts
maintain positional memory in culture enabling them to organize
themselves as seen in the joint (Calvo et al., 2017). Building
upon this, organoids consisting of fibroblasts and endothelial cells
suspended in a matrigel droplet revealed that up-regulation of
NOTCH3 ligands on the vasculature help to drive the spatial
organization of fibroblasts into lining and sublining layers, where
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FIGURE 3 | The multi-step adhesion cascade in chronically inflamed joints. The etiology of most inflammatory arthritides remains unknown. At some point during the
initial phases of disease, the endothelial cells up-regulate the expression of the typical adhesion molecules (E and P selectin, VCAM), as well as other molecules
usually found in HEV venules (PNAd) or the gut (VAP-1). Furthermore, fibroblasts switch from homeostatically anti-inflammatory, to actively pro-inflammatory with the
production of chemokines (CXCL5 and CXCL12) that are shuttled to the endothelium. Leukocytes from arthritic patients exhibit higher expression of integrins, such
as αLβ2-, αMβ2-, and α6-, and are recruited to the endothelium via P-selectin (neutrophils) and α4β1-integrin-VCAM-1 interactions (lymphocytes). Increased
expression of α5β1, αvβ3, and α6 integrins on leukocytes aids their migration through the basement membrane and tissue, whilst fibroblast interactions with T and B
cells increases pseudoemperipolesis. Molecules are colored according to cell type: leukocytes = blue and endothelial cells = red, and highlighted bold to denote
major contributors to infiltration during inflammatory arthritis, but not in response to infection or damage. PNAd, peripheral node addressin; VAP-1, vascular adhesion
protein 1; VCAM-1, vascular adhesion protein 1. Created with BioRender.com.
deletion of NOTCH3 reduced the clinical score and inflammatory
infiltrated observed by H&E in mice with STIA (Wei et al.,
2020). Crucially a subpopulation of synovial fibroblast (fibroblast
activation protein α+; FAPα+) is responsible for driving
leukocyte infiltration in STIA mice, where deleting FAPα+
fibroblasts reduced leukocyte numbers in the arthritic joint (Croft
et al., 2019). Collectively these studies highlight the importance
of fibroblast subtypes in regulating leukocyte trafficking and
the ability of endothelial cells to influence the phenotype of
the neighboring stroma, but crucially they demonstrate the
possibility of modeling the human diseased joint using fibroblast-
endothelial cell 3-D organoids in vitro. Of note, tumor and
mural organoid models incorporating mesodermal progenitor
cells were able to form a hierarchical structure of blood vessels
(Wörsdörfer et al., 2019), suggesting the same could be done and
used to model the vasculature in inflammatory arthritides.
Advances in 3-D printing are driving forward the field of
microfluidic modeling of leukocyte recruitment in a disease
context (Sackmann et al., 2012; Venugopal Menon et al., 2018),
where incorporating precious, but limited, patient material into
high-throughput mechanistic screening studies is becoming a
reality. Such systems have effectively mimicked the disturbed
flow patterns seen in vessel bifurcations, highlighting these as
areas where endothelial cells can support the recruitment of
the monocyte cell line, THP-1 – as seen in atherosclerosis
(Khan and Sefton, 2011). Hence microfluidic channels may
help to elucidate the disparities seen in the vascular patterns
in patients with PsA and RA (Kennedy et al., 2010). Addition
of collagen scaffolds; tuneable chemical gradients (Wu et al.,
2017) and stromal cells, to the microfluidic channels are paving
the way for the development of personalized “organs-on-a-chip”
which present the possibility of precision medicine (Van Den
Berg et al., 2019). In the context of inflammatory arthritis,
microfluidic systems have been used to track the migration of
the cadherin-11 expressing synovial cell line (SW982) toward an
activated osteoclast cell line (RAW264.7), where the co-culture
construct enhanced SW982 migration and osteoclast activity
compared to the monocultures (Ma et al., 2018). Moreover,
3-D “synovium-on-a-chip” with an integrated time-resolved
light scatter biosensor has been generated that allows the
visualization of TNFα induced fibroblast organization into lining
and sublining layers over 2 days (Rothbauer et al., 2020) (e.g.,
Figure 2G). Incorporating endothelial cells and leukocytes into
such models would enable in vivo like analysis of recruitment
and it is most likely only a matter of time before these are
generated. Furthermore, other in vivo like constructs are being
formed, such as the living vascular tissue fabricated by direct
culture of collagen, smooth muscle cells and endothelial cells,
presenting another way to move away from in vivo models, whilst
accessing leukocyte infiltration (Meghezi et al., 2015). These
studies highlight how rapidly microfluidic and in vivo models are
improving, providing the opportunity to access multiple cell:cell
interactions, whilst also mimicking physiological aspects such
as blood flow. This is crucial in understanding inflammatory
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diseases such as RA, PsA and IA, which are known to be driven
by uncontrolled leukocyte recruitment, but exactly how and why
this occurs is yet to be elucidated.
The era of precision medicine for inflammatory arthritis
is fast approaching (reviewed by Aletaha, 2020; Miyagawa
and Tanaka, 2020) with “big data” providing insights into
different patient populations and further subgrouping patients
according to their underlying process driven pathology – yet
imaging remains crucial for initial discoveries and confirming
outputs of omics analysis (e.g., Lewis et al., 2019). Indeed,
the use of synovial tissue signatures improves the prediction
that a patient will require biological therapy 12 months after
diagnosis (Lliso-Ribera et al., 2019). Furthermore, advances in
spatial transcriptomics now enables mapping of gene expression
profiles onto images of tissues, providing for the first-time
spatial context to gene expression data (Burgess, 2019). Such
technology has revealed that central memory T-cells were
dominant in RA synovial tissue sections, whilst in SpA tissues
effector memory T-cells were most prominent (Carlberg et al.,
2019), and thus will enable more targeted therapies to be
delivered to these patients in the future. Advances in imaging
technologies, in particular the “synovium-on-a-chip” described
above, incorporating patient synovial material provides the
opportunity to pre-screen possible treatment options based on
identified “patient specific signatures,” ultimately offering the
realistic hope of achieving precision medicine for all patients
based on their cellular and molecular processes driving their
disease pathology.
CONCLUSION
Significant advances in imaging modalities over the last 60 years
have vastly improved our understanding of leukocyte infiltrates
in the inflamed joints in numerous inflammatory arthritides in
patients as well as in vitro/in vivo models. It is evidently clear
that the local microenvironment of an inflamed joint dictates
the spatiotemporal dynamics of leukocyte entry and egress, and
it is highly likely this differs in different regions of a given
joint, between patients, as the disease evolves and in response
to treatments. Despite our advances, there is still much we do
not fully understand particularly in the context of human disease,
and for that further advances are needed to image these processes
directly in patients but more realistically to enable the imaging of
complex in vitro constructs of a patient’s joint microenvironment.
Only then will we be able to truly map the spatiotemporal
dynamics and molecular mechanisms for a patient at a given
time point in their disease history. Ultimately the aim would be
to develop drug combinations that can limit the trafficking of
pathogenic effector leukocytes whilst promoting the function and
presence of regulatory leukocytes to switch off the inflammatory
response and induce clinical remission/cure the disease.
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